Bacsan, Liam F.

HRN: 21-87-60  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2022
AMPICILLIN 500MG (VIAL)
09/03/2022
09/09/2022
IV
100mg
Q6hrs
Neonatal Pneumonia
Waiting Final Action 
09/03/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/03/2022
09/09/2022
IV
52mg
OD
Neonatal Pneumonia
Waiting Final Action 
09/09/2022
CEFTAZIDIME 1GM (VIAL)
09/09/2022
09/16/2022
IV
105mg
Q8
Neonatal Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: